0001730907-18-000002.txt : 20181026 0001730907-18-000002.hdr.sgml : 20181026 20181026114141 ACCESSION NUMBER: 0001730907-18-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181026 DATE AS OF CHANGE: 20181026 EFFECTIVENESS DATE: 20181026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aclipse Therapeutics LLC CENTRAL INDEX KEY: 0001730907 IRS NUMBER: 823570666 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-305769 FILM NUMBER: 181140881 BUSINESS ADDRESS: STREET 1: 832 12TH STREET CITY: OAKMONT STATE: PA ZIP: 15139 BUSINESS PHONE: 614-333-9938 MAIL ADDRESS: STREET 1: 832 12TH STREET CITY: OAKMONT STATE: PA ZIP: 15139 FORMER COMPANY: FORMER CONFORMED NAME: Aclipse Therapeutics, LLC DATE OF NAME CHANGE: 20180209 D/A 1 primary_doc.xml X0708 D/A LIVE 0001730907 Aclipse Therapeutics LLC 170 North Radnor Chester Road Suite 350 RADNOR PA PENNSYLVANIA 19087 412-606-7214 DELAWARE Aclipse Therapeutics, LLC Limited Liability Company true 2017 Raymond K Houck 157 River Road Pasadena MD MARYLAND 21122 Executive Officer Director Pharmaceuticals Decline to Disclose 06b true 0001437377-18-000002 2018-01-31 true true true false 0 Indefinite 1075000 Indefinite false 3 0 0 0 false Aclipse Therapeutics LLC /s/ Raymond K. Houck Raymond K. Houck President and CEO 2018-10-26